SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Company | Pharmaceuticals, Biotechnology and Life Sciences | Asia | Targets set | Large | 5 | Sep 19, 2024 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year - Long-Term Status Targets set Net-Zero Status Targets set Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Asia Organization Type Corporate Location Japan Company Size Large Target Statement Overall Net-Zero Target: Takeda Pharmaceutical Company Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2040. Near-Term Targets: Takeda Pharmaceutical Company commits to reduce absolute scope 1 and 2 GHG emissions 65% by FY2030 from a FY2016… Stakeholders Global Head of Environmental Sustainability Chief Global Corporate Affairs & Sustainability Officer Dieter Weiss Head of Supplier ESG, Global Procurement Bridget Ferrari Director, Supply Chain Sustainability Sebastien Bals Chief Procurement Officer | |||||||
Turn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.